Patient
SITE010-0101
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2026-01-01
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-18 (study day 196); relationship: NOT RELATED
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-25 (study day 172); relationship: NOT RELATED
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-11-17 (study day 134); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-11-05 (study day 122); relationship: not assessed
Grade 3 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-11-04 (study day 121); relationship: not assessed
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-08-22 (study day 47); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.